Novation MedTech secures strategic seed funding for AI-powered ultrasound platform

Recently, Novation MedTech announced the completion of a nearly ten-million-yuan seed funding round from a renowned investment institution and several seasoned medical industry professionals. Concurrently, the company has initiated its Series A financing round. The proceeds will be primarily allocated to advancing clinical trials, expanding the product pipeline, and pursuing overseas market registrations.

Founded by a veteran team with decades of experience in the healthcare sector, Novation MedTech is committed to building a globally leading platform for non-invasive, non-metabolic intervention powered by AI-precision-driven ultrasound technology. The company focuses on high-growth areas such as combating skin aging, reshaping body contours, and ablating redundant fat.

Novation MedTech's core technology platform is designed to integrate multiple modules, including 3D individualized energy planning for body contouring, AI-assisted precision guidance, non-invasive superficial ultrasound ablation, and plastic outcome data tracking and management. Equipped with high-precision ultrasound imaging, AI algorithm-assisted diagnosis, and personalized treatment pathway planning, the platform significantly enhances the precision and standardization of skin treatments and body shaping procedures in aesthetic institutions. This not only reduces reliance on physician experience but also enables closed-loop management spanning "diagnosis, assessment, treatment, and follow-up" in medical aesthetic scenarios.

Novation MedTech's product platform is characterized by its non-invasive nature, multi-layer targeting, customizable planning, and precise immediate contouring capabilities. Through a full-cycle, precision closed-loop management process—encompassing efficient pre-operative simulation, accurate intra-operative energy delivery, and quantitative post-operative tracking—the platform enables faster achievement of desired outcomes for skin improvement and body contouring needs, without requiring dietary control or pharmaceutical intervention. Furthermore, leveraging its AI technology and integrated ultrasound diagnosis-therapy platform, Novation MedTech is actively expanding the application of its real-time ultrasound-guided ablation solutions into various scenarios, such as thyroid nodule ablation.

The integration of AI technology is fundamentally reshaping the utilization and clinical value of ultrasound devices. Firstly, AI systems can provide real-time guidance for standard imaging planes, automate parameter measurements, and assess image quality during ultrasound scans, significantly reducing dependence on operator experience and enhancing service capabilities in primary healthcare institutions. Secondly, by integrating patient imaging, medical history, and clinical data, AI can assist in generating personalized treatment recommendations. Particularly in the aesthetic field, this enables an intelligent end-to-end process encompassing "skin condition assessment, treatment parameter recommendation, efficacy prediction, and post-treatment follow-up." Furthermore, the combination of AI and robotics has enabled the decoupling of remote ultrasound scanning from diagnosis. Specialists can conduct diagnostics via cloud platforms, while primary operators need only perform standardized scans, thereby addressing disparities in healthcare resource distribution. Lastly, through the fusion of ultrasound imaging and clinical data, AI facilitates the development of efficacy prediction models, enabling dynamic outcome assessment and protocol optimization in scenarios such as tumor ablation, dermatological therapies, and fat management.

Currently, Novation MedTech's inaugural product has completed engineering prototype development and is poised to enter the registration clinical trial phase, with anticipated submission for China NMPA Class III medical device registration in 2026. Over the next five years, the company plans to pursue Class III indications addressing needs in body contouring, fat management, collagen restoration, skin rejuvenation, and ultrasound-guided surgical treatment systems. The roadmap includes launching multiple specialized AI-integrated ultrasound diagnosis-therapy devices while concurrently advancing FDA certification to expand into global markets.